Mga Batayang Estadistika
| CIK | 1501972 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sanomedics, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| March 30, 2016 |
simhnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER 801063405 (Check One): x Form 10-K ? Form 20-F ? Form 10-Q ? Form 10-D ? Form N-SAR For Period Ended: December 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Rep |
|
| March 14, 2016 |
simh8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 12, 2016 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commissi |
|
| March 14, 2016 |
AGREEMENT BY AND AMONG POSITIVE ID CORPORATION, SANOMEDICS, INC. AND THERMOMEDICS, INC. EX-10.96 2 simhex1096.htm MANAGEMENT SERVICES AND CONTROL AGREEMENT EXHIBIT 10.96 AGREEMENT BY AND AMONG POSITIVE ID CORPORATION, SANOMEDICS, INC. AND THERMOMEDICS, INC. This AGREEMENT is entered into as of March 4, 2016 by and among Positive ID Corporation, a Delaware corporation (the "Company"); Sanomedics, Inc., a Delaware Corporation ("Sano") and, its wholly-owned subsidiary, Thermomedics, Inc |
|
| January 22, 2016 |
Sanomedics AMENDMENT TO SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) January 22, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 21, 2016 |
Sanomedics SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) January 21, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| January 19, 2016 |
Regulation FD Disclosure, Unregistered Sales of Equity Securities, Financial Statements and Exhibits pdfproof.pdf UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C, 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 9, 2015 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Comm |
|
| January 19, 2016 |
sanoex991.htm EXHIBIT 99.1 SOURCE: Sanomedics, Inc. January 14, 2016 08:00 ET Sanomedics Eliminates Over $500,000 in Convertible Notes to Strengthen Company's Balance Sheet MIAMI, FL-(Marketwired - Jan 14, 2016) - Sanomedics, Inc. (OTC PINK: SIMH) ("Sanomedics" or the "Company"), a medical technology holding company that focuses on providing game changing products, services and ideas, announced to |
|
| January 14, 2016 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) January 13, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| January 8, 2016 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) January 8, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| January 6, 2016 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) January 6, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| December 31, 2015 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 24, 2015 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) December 24, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 23, 2015 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) December 22, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 18, 2015 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) December 18, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 16, 2015 |
SIMH / Sanomedics, Inc. / Rainman Capital LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 801063405 (CUSIP Number) December 15, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| December 16, 2015 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) December 15, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 15, 2015 |
sano8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 14, 2015 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commiss |
|
| December 10, 2015 |
8-K 1 sano8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 4, 2015 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorpora |
|
| December 10, 2015 |
MANAGEMENT SERVICES AND CONTROL AGREEMENT sanoex1093.htm EXHIBIT 10.93 EXECUTION COPY MANAGEMENT SERVICES AND CONTROL AGREEMENT THIS MANAGEMENT SERVICES AND CONTROL AGREEMENT (the "Agreement"), effective as of December 4, 2015, is made by and between PositiveID Corporation, a Delaware corporation (the "Company" or "Manager"), Sanomedics, Inc., a Delaware corporation ("Sano") and, its wholly-owned subsidiary, Thermomedics, Inc., a Nevada c |
|
| December 10, 2015 |
sanoex1095.htm EXHIBIT 10.95 EXECUTION COPY SECURITY AGREEMENT This Security Agreement (this "Agreement"), is made as of 4th day of December, 2015 by and between PositiveID Corporation, a Delaware corporation (the "Secured Party"); and Sanomedics, Inc., a Delaware corporation ("Debtor")(together, the "Parties"). RECITALS: A. Thermomedics, Inc., a Nevada corporation and wholly owned subsidiary of t |
|
| December 10, 2015 |
EX-10.92 2 sanoex1092.htm FIRST AMENDMENT EXHIBIT 10.92 EXECUTION COPY FIRST AMENDMENT TO STOCK PURCHASE AGREEMENT by and between POSITIVE ID CORPORATION and SANOMEDICS, INC., SHAREHOLDER OF THERMOMEDICS, INC. This FIRST AMENDMENT is made as of December 4, 2015 by and between Positive ID Corporation, a Delaware corporation ("Buyer") and Sanomedics, Inc., a Delaware Corporation ("Seller"). RECITALS |
|
| December 10, 2015 |
sanoex1094.htm EXHIBIT 10.94 EXECUTION COPY SECURITY AGREEMENT This Security Agreement (this "Agreement"), is made as of 4th day of December, 2015 by and between PositiveID Corporation, a Delaware corporation (the "Secured Party"); and Thermomedics, Inc., a Nevada corporation ("Debtor") (together, the "Parties"). RECITALS: A. The Debtor, Secured Party and Sanomedics, Inc., a Delaware corporation a |
|
| December 8, 2015 |
SIMH / Sanomedics, Inc. / Beaufort Capital Partners, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sanomedics, Inc. (Name of Issuer) Common Stock, Par Value $0 .01 (Title of Class of Securities) 801063405 (CUSIP Number) December 7, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| November 24, 2015 |
Termination of a Material Definitive Agreement simh8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 18, 2015 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commiss |
|
| November 16, 2015 |
Sanomedics FORM 10-Q (Quarterly Report) simh10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54167 |
|
| October 26, 2015 |
simhex1091.htm EXHIBIT 10.91 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT, dated as of October 21, 2015, (this "Agreement"), is made and entered into by and among The Brace Shop, LLC, a [Florida] limited liability company (the "Company"), Mrs. Lynne Shapiro (the "Seller") and Sanomedics, Inc., a Delaware corporation ("Buyer"). P R E M I S E S: WHEREAS, the Buyer is engaged in the busines |
|
| October 26, 2015 |
simhex1090.htm EXHIBIT 10.90 STOCK PURCHASE AGREEMENT by and between POSITIVEID CORPORATION and SANOMEDICS, INC. SHAREHOLDER OF THERMOMEDICS, INC. Dated as of October 21, 2015 1 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this ?Agreement?), dated as of October 21, 2015 is entered into between PositiveID Corporation, a Delaware corporation (?Buyer?) and Sanomedics, Inc., a Delaware corp |
|
| October 26, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits simh8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2015 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commissi |
|
| October 23, 2015 |
simhprer14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. 1) Check the appropriate box: x Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement SA |
|
| October 22, 2015 |
simhpre14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement SANOMEDICS, INC. (Nam |
|
| October 13, 2015 |
simhex37.htm EXHIBIT 3.7 |
|
| October 13, 2015 |
simh8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 12, 2015 Sanomedics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commissi |
|
| September 16, 2015 |
simhdef14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission only (as permitted by Rule 14c-5(d) (2)) x Definitive Information Statement SANOMEDICS, INC. (Name of Regist |
|
| August 24, 2015 |
simhprer14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Check the appropriate box: x Preliminary Information Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14c-5(d) (2)) ? Definitive Information Statement SANOMEDICS, I |
|
| August 18, 2015 |
simhpre14c.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for Use of the Commission only (as permitted by Rule 14c-5(d) (2)) ¨ Definitive Information Statement SANOMEDICS, INC |
|
| July 6, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 1, 2015 Sanomedics, Inc. |
|
| July 6, 2015 |
EXHIBIT 16.1 July 6, 2015 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Sanomedics, Inc. under Item 4.01 of its Form 8-K dated July 1, 2015. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Sanomedics, Inc. contained therein. Very |
|
| May 26, 2015 |
SIMH / Sanomedics, Inc. / CLSS HOLDINGS LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. ) SANOMEDICS, INC. (Name of issuer) Common Stock, $0.001 value per share (Title of class of securities) 801063306 (CUSIP number) May 22, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER 801063-10-8 (Check One): Form 10-K ? Form 20-F x Form 10-Q ? Form 10-D ? Form N-SAR For Period Ended: March 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K x Transition Report on Form 10-Q |
|
| April 21, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 14, 2014 Sanomedics, Inc. |
|
| April 2, 2015 |
SIMH / Sanomedics, Inc. / PURE ENERGY 714 LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Sanomedics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 801063207 (CUSIP Number) Pure Energy 714, LLC 21 Ridge Rd. Atlantic Highlands, NJ 07716 732-931-2035 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications |
|
| March 31, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER (Check One): x Form 10-K ? Form 20-F ? Form 10-Q ? Form 10-D ? Form N-SAR For Period Ended: December 31, 2014 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Trans |
|
| February 13, 2015 |
EXHIBIT 10.87 1 2 3 4 5 6 7 8 9 10 11 |
|
| February 13, 2015 |
EXHIBIT 10.88 1 2 3 4 5 6 7 8 9 10 11 |
|
| February 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2015 Sanomedics, Inc. |
|
| February 13, 2015 |
EXHIBIT 10.85 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 |
|
| February 13, 2015 |
EXHIBIT 10.86 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 |
|
| February 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 6, 2015 Sanomedics International Holdings, Inc. |
|
| February 6, 2015 |
EXHIBIT 3.6 1 2 |
|
| February 5, 2015 |
EXHIBIT 16.1 January 30, 2015 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated January 30, 2015 of Sanomedics International Holdings, Inc., and are in agreement with the statements contained in paragraphs 2, 3 and 4 on page 2 therein. We have no basis to agree or disagree with other statements of the registr |
|
| February 5, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2015 Sanomedics International Holdings, Inc. |
|
| January 20, 2015 |
SIMH / Sanomedics, Inc. DEF 14C - - DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission only (as permitted by Rule 14c-5(d) (2)) x Definitive Information Statement SANOMEDICS INTERNATIONAL HOLDI |
|
| January 7, 2015 |
SIMH / Sanomedics, Inc. PRE 14C - - PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for Use of the Commission only (as permitted by Rule 14c-5(d) (2)) ¨ Definitive Information Statement SANOMEDICS INTERNATIONAL HOLDI |
|
| October 31, 2014 |
Date of Issuance: 10/24/14 13% CONVERTIBLE DEBENTURE DUE 4/24/15 EXHIBIT 10.77 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI |
|
| October 31, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 24, 2014 Sanomedics International Holdings, Inc. |
|
| October 31, 2014 |
Date of Issuance: 10/24/14 13% CONVERTIBLE DEBENTURE DUE 4/24/15 EXHIBIT 10.78 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI |
|
| October 24, 2014 |
Sanomedics International Holdings, Inc. EXHIBIT 99.1 Sourse: Sanomedics International Holdings, Inc. October 21, 2014 15:02 ET Sanomedics Completes Financing; Settles Creditor Litigation MIAMI, Oct. 21, 2014 (GLOBE NEWSWIRE) - Sanomedics International Holdings, Inc. (OTCQB:SIMH), (the "Company") a medical technology and services holding company that focuses on providing game changing products, services and ideas, is pleased to announce |
|
| October 24, 2014 |
EXHIBIT 10.75 AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT (this "Agreement"), dated and effective as of October 17th, 2014 (the "Effective Date"), is executed by and between Redwood Management, LLC, a limited liability company organized and existing under the laws of the State of Florida ("Redwood"), and Sanomedics International Holdings, Inc., a Delaware corporation, Thermomedics, Inc., a Florid |
|
| October 24, 2014 |
REPLACEMENT REVOLVING NOTE A -3 $1,225,153.61 Issuance Date: as of October 17, 2014 EXHIBIT 10.76 NEITHER THIS NOTE NOR THE SECURITIES THAT ARE ISSUABLE TO THE HOLDER UPON CONVERSION HEREOF (COLLECTIVELY, THE "SECURITIES") HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THE SECURITIES NOR ANY INTEREST OR PARTICIPATION THEREIN MAY BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNE |
|
| October 24, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 17, 2014 Sanomedics International Holdings, Inc. |
|
| October 23, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Sanomedics International Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 801063207 (CUSIP Number) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: o Rule 13d-1(b) x Rule 13d-1(c) o Rule 1 |
|
| October 21, 2014 |
SIMH / Sanomedics, Inc. / UNION CAPITAL, LLC - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 SANOMEDICS INTERNATIONAL HOLDINGS, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 801063207 (CUSIP Number) October 13, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| October 17, 2014 |
EXHIBIT 99.1 Sanomedics Announces Initial Purchase of Nearly 100 Caregiver(R) TouchFree(TM) Clinical Thermometers to Help Fight Against EBOLA at the Nation's Airports MIAMI, Oct. 10, 2014 (GLOBE NEWSWIRE) - Sanomedics International Holdings, Inc. (OTCQB:SIMH); "Sanomedics" or the "Company"); a medical technology holding company that focuses on providing game changing products, services and ideas, |
|
| October 17, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 10, 2014 Sanomedics International Holdings, Inc. |
|
| September 29, 2014 |
Sanomedics Restructures Debt as it Looks to Strengthen Balance Sheet September 29, 2014: 07:59 AM ET EXHIBIT 99.1 Sanomedics Restructures Debt as it Looks to Strengthen Balance Sheet September 29, 2014: 07:59 AM ET MIAMI, Sept. 29, 2014 (GLOBE NEWSWIRE) - Sanomedics International Holdings, Inc. (OTCQB:SIMH), a medical technology and services holding company that focuses on providing game changing products, services and ideas, announced today that the Company entered into a series of agreements to |
|
| September 29, 2014 |
EXHIBIT 10.74 |
|
| September 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 23, 2014 Sanomedics International Holdings, Inc. |
|
| September 29, 2014 |
EXHIBIT 10.72 AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT (this "Agreement"), dated and effective as of September 22, 2014 (the "Effective Date"), is executed by and between Redwood Management, LLC, a limited liability company organized and existing under the laws of the State of Florida ("Redwood"), and Sanomedics International Holdings, Inc., a Delaware corporation, Thermomedics, Inc., a Florid |
|
| September 29, 2014 |
REPLACEMENT REVOLVING NOTE A $117,074.91 Issuance Date: as of September 22, 2014 EXHIBIT 10.73 NEITHER THIS NOTE NOR THE SECURITIES THAT ARE ISSUABLE TO THE HOLDER UPON CONVERSION HEREOF (COLLECTIVELY, THE "SECURITIES") HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THE SECURITIES NOR ANY INTEREST OR PARTICIPATION THEREIN MAY BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNE |
|
| August 14, 2014 |
SIMH / Sanomedics, Inc. NT 10-Q - - NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER 801063-10-8 (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR For Period Ended: June 30, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report |
|
| June 17, 2014 |
SIMH / Sanomedics, Inc. / ASHER ENTERPRISES INC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Name of issuer) Common Stock, $0.001 value per share (Title of class of securities) 801063207 (CUSIP number) January 23, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER 801063-10-8 (Check One): o Form 10-K o Form 20-F x Form 10-Q o Form 10-D o Form N-SAR For Period Ended: March 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10- |
|
| March 31, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER (Check One): x Form 10-K o Form 20-F o Form 10-Q o Form 10-D o Form N-SAR For Period Ended: December 31, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Trans |
|
| March 28, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 13, 2014 Sanomedics International Holdings, Inc. |
|
| February 25, 2014 |
EXHIBIT 99.1 Sanomedics Announces Letter of Intent to Acquire a Leading Provider of Professional Health Care Services and Solutions MIAMI, Feb. 25, 2014 /PRNewswire/ - Sanomedics International Holdings, Inc. (OTCQB: SIMH) ("Sanomedics"), a medical technology holding company that focuses on game-changing products, services and ideas, today announced that on February 21, 2014, it has entered into a |
|
| February 25, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 21, 2014 Sanomedics International Holdings, Inc. |
|
| January 23, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 23, 2014 Sanomedics International Holdings, Inc. |
|
| January 16, 2014 |
EXHIBIT 10.51 |
|
| January 16, 2014 |
EXHIBIT 10.48 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
|
| January 16, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2014 Sanomedics International Holdings, Inc. |
|
| January 16, 2014 |
EXHIBIT 10.49 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
|
| January 16, 2014 |
EXHIBIT 10.50 1 2 3 4 5 6 7 8 |
|
| January 16, 2014 |
EX-10.47 3 simhex1047.htm REVOLVING NOTE EXHIBIT 10.47 |
|
| January 16, 2014 |
EXHIBIT 10.46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 |
|
| January 16, 2014 |
EXHIBIT 99.1 1 2 |
|
| December 31, 2013 |
SIMH / Sanomedics, Inc. / ASHER ENTERPRISES INC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Name of issuer) Common Stock, $0.001 value per share (Title of class of securities) 801063207 (CUSIP number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| December 30, 2013 |
Termination of a Material Definitive Agreement - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 23, 2013 Sanomedics International Holdings, Inc. |
|
| December 20, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A Amendment No. |
|
| December 20, 2013 |
EXHIBIT 3.5 |
|
| December 19, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2013 Sanomedics International Holdings, Inc. |
|
| December 19, 2013 |
EXHIBIT 3.5 1 2 |
|
| November 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER 801063-10-8 (Check One): o Form 10-K o Form 20-F x Form 10-Q o Form 10-D o Form N-SAR For Period Ended: September 30, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form |
|
| November 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement Sanomedics Internat |
|
| October 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement Sanomedics Internat |
|
| September 6, 2013 |
Sanomedics International Holdings, Inc. PROMISSORY NOTE EXHIBIT 10.51 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED. Sanomedics International Holdings, Inc. PROMISSORY NOTE N |
|
| September 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 30, 2013 Sanomedics International Holdings, Inc. |
|
| September 6, 2013 |
EXHIBIT 10.54 SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Agreement”) is made and entered into as of August 30, 2013, by and among Sanomedics International Holdings, Inc., a Delaware corporation ("Company"), and Anovent, Inc., a Florida corporation (“Buyer” and collectively with Company, “Maker”) jointly and severally promise to pay to Mark R. Miklos (the “Lender”). 1. Grant of Security Inte |
|
| September 6, 2013 |
EXHIBIT 10.55 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement"), dated as of August 30, 2013, is made by and between Sanomedics International Holdings, Inc., a Delaware corporation (“Parent”), Anovent, Inc., a Florida corporation (“Buyer”), Prime Time Medical, Inc., a Florida corporation, having an address at 7201 Bryan Dairy Rd, Largo, FL 33777 (the “Company”), and Mark R. Miklos, havi |
|
| September 6, 2013 |
AMENDMENT TO STOCK PURCHASE AGREEMENT EXHIBIT 10.50 AMENDMENT TO STOCK PURCHASE AGREEMENT This Amendment (the “Amended Agreement”) is dated as of August 30, 2013 and amends that certain Stock Purchase Agreement (the “Original Agreement”) dated April 26, 2013, by and among Sanomedics International Holdings, Inc., a Delaware corporation (“Parent”), Anovent, Inc., a Florida corporation (“Buyer”), Prime Time Medical, Inc., a Florida corpo |
|
| September 6, 2013 |
Sanomedics International Holdings, Inc. PROMISSORY NOTE EXHIBIT 10.52 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED. Sanomedics International Holdings, Inc. PROMISSORY NOTE N |
|
| September 6, 2013 |
Sanomedics International Holdings, Inc. PROMISSORY NOTE EXHIBIT 10.53 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED. Sanomedics International Holdings, Inc. PROMISSORY NOTE N |
|
| September 4, 2013 |
EXHIBIT 10.48 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| September 4, 2013 |
EXHIBIT 10.47 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 27, 2013, by and between SANOMEDICS INTERNATIONAL HOLDINGS, INC., a Delaware corporation, with headquarters located at 444 Brickell Avenue - Suite 415, Miami, FL 33131 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its address at 1 Linden Place, Suite 207 |
|
| September 4, 2013 |
Sanomedics Announces Completion of Prime Time Medical Acquisition EXHIBIT 99.1 Sanomedics Announces Completion of Prime Time Medical Acquisition MIAMI, Sept. 3, 2013 /PRNewswire/ - Sanomedics International Holdings, Inc. (OTCQB: SIMH) ("Sanomedics"), a medical technology holding company that focuses on game-changing products, services and ideas, today announced that it has completed the previously announced acquisition of Prime Time Medical, Inc., of Largo, Flor |
|
| September 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 30, 2013 Sanomedics International Holdings, Inc. |
|
| August 26, 2013 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 26, 2013 Sanomedics International Holdings, Inc. |
|
| August 26, 2013 |
Sanomedics Receives Financing for Working Capital and Acquisitions Exhibit 99.1 Sanomedics Receives Financing for Working Capital and Acquisitions MIAMI, Aug. 26, 2013 /PRNewswire/ - Sanomedics International Holdings, Inc. (OTCQB: SIMH) ("Sanomedics"), a medical technology holding company that focuses on game-changing products, services and ideas, announced today that it has entered into a financing term sheet with MC Healthcare Finance LLC for a total $5,000,000 |
|
| August 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER 801063-10-8 (Check One): o Form 10-K o Form 20-F x Form 10-Q o Form 10-D o Form N-SAR For Period Ended: June 30, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q |
|
| July 16, 2013 |
EXHIBIT 99.1 Sanomedics Signs Definitive Agreement for Acquisition of a prominent Texas based Sleep Services company. By PR Newswire, July 11, 2013, 06:57:00 AM EDT MIAMI, July 11, 2013 /PRNewswire/ - Sanomedics International Holdings, Inc. (OTCQB:SIMH) ("Sanomedics"), a medical technology company that focuses on market expanding products and services announced that it has entered into a definitiv |
|
| July 16, 2013 |
EXHIBIT 10.42 EQUITY PURCHASE AGREEMENT EQUITY PURCHASE AGREEMENT, dated as of 10th July 2013, by and among Sanomedics International Holdings, Inc., a Delaware corporation (“Parent”), Anovent, Inc., a Florida corporation (“Buyer”), Duke Medical Equipment LLC, a Texas limited liability company (the “Company”), and Vann R. Duke, the sole equity holder of the Company (“Seller”). W I T N E S S E T H: |
|
| July 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2013 Sanomedics International Holdings, Inc. |
|
| June 24, 2013 |
EXHIBIT 10.41 1 2 3 |
|
| June 24, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 19, 2013 Sanomedics International Holdings, Inc. |
|
| May 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 26, 2013 Sanomedics International Holdings, Inc. |
|
| May 3, 2013 |
EXHIBIT 99.1 Sanomedics Signs Definitive Agreement to Acquire Prime Time Medical Apr 29, 2013 Sanomedics Signs Definitive Agreement to Acquire Prime Time Medical PR Newswire MIAMI, April 29, 2013 MIAMI, April 29, 2013 /PRNewswire/ - Sanomedics International Holdings, Inc. (OTCQB: SIMH) ("Sanomedics"), a medical technology holding company that focuses on game-changing products, services and ideas, |
|
| May 3, 2013 |
EXHIBIT 10.39 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIE |
|
| March 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER (Check One): x Form 10-K o Form 20-F o Form 10-Q o Form 10-D o Form N-SAR For Period Ended: December 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Trans |
|
| March 11, 2013 |
8-K 1 simh8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 11, 2013 Sanomedics International Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other juri |
|
| March 11, 2013 |
EXHIBIT 99.1 Mr. William Lerner, Esq. nominated to the Board of Directors of Sanomedics International Holdings, Inc. MIAMI, FLORIDA, March 8, 2013 /PRNewswire via COMTEX/ - Sanomedics International Holdings, Inc. (OTCQB: SIMH), a medical technology holding Company that focuses on game changing products, services and ideas, announces that William Lerner, Esq. has been nominated to serve as a direct |
|
| January 8, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported: December 31, 2012 SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commiss |
|
| January 8, 2013 |
EXHIBIT 10.36 1 2 3 |
|
| December 11, 2012 |
Exhibit 10.34 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 6, 2012, by and between SANOMEDICS INTERNATIONAL HOLDINGS, INC., a Delaware corporation, with headquarters located at 80 SW 8th Street - Suite 2180, Miami, FL 33130 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its address at 1 Linden Place, Suite 207, |
|
| December 11, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported: December 6, 2012 SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commissi |
|
| December 11, 2012 |
Exhibit 10.35 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| November 14, 2012 |
- SANOMEDICS INTERNATIONAL HOLDINGS, INC. FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER (Check One): o Form 10-K o Form 20-F x Form 10-Q o Form 10-D o Form N-SAR For Period Ended: September 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q |
|
| October 25, 2012 |
Regulation FD Disclosure - SANOMEDICS INTERNATIONAL HOLDINGS, INC FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported: October 17, 2012 SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commissi |
|
| August 14, 2012 |
RESIGNATION LETTER August 13, 2012 Sanomedics International Holdings Inc. 80 SW 8th Street Suite 2180 Miami, FL 33180 Gentlemen: This letter confirms that I hereby resign from the Board of Directors of Sanomedics International Holdings Inc. (the "Corporation"). My resignation is not the result of any disagreement with the Corporation on any matter relating to its operation, policies (including acc |
|
| August 14, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported: August 13, 2012 SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commissio |
|
| May 15, 2012 |
- SANOMEDICS INTERNATIONAL HOLDINGS, INC FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54167 CUSIP NUMBER (Check One): oForm 10-K oForm 20-F xForm 10-Q Foorm 10-D oForm N-SAR For Period Ended: March 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transit |
|
| April 27, 2012 |
8-K 1 form8k.htm SANOMEDICS INTERNATIONAL HOLDINGS, INC FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported: April 25, 2012 SANOMEDICS INTERNATIONAL HOLDINGS, INC. [Missing Graphic Reference] (Exact name of Registrant as specified in its char |
|
| April 27, 2012 |
Exhibit 99.1 Dom Gatto Chairman Sanomedics 80 SW 8th St. Suite 2180, Miami, FL 33130 April 25, 2012 Dear Dom, I am writing to inform you of my decision to resign my position on the Board of Sanomedics, effective immediately. My other commitments have become too great for me to be able to fulfill the requirements of my position on the Board. If I can be of any assistance during the time it will tak |
|
| April 10, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported: March 26, 2012 SANOMEDICS INTERNATIONAL HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Delaware 000-54167 27-3320809 (State or other jurisdiction of incorporation) (Commission |
|
| March 30, 2012 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-54167 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Tra |
|
| January 9, 2012 |
Sanomedics International Holdings, Inc. 80 SW 8th Street – Suite 2180 Miami, FL 33130 January 9, 2012 Securities and Exchange Commission Division of Corporate Finance 450 Fifth Street N.W. Washington, DC 20549-0305 Attn: Kevin Vaughn Re: Sanomedics International Holdings, Inc. (the “Company”) Form 8K; Filed December 30, 2011 SEC File No.: 000-54167 Gentlemen: The Company hereby acknowledges the fo |
|
| January 6, 2012 |
Financial Statements and Exhibits - SANOMEDICS INTERNATIONAL HOLDINGS, INC FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Current Report PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report ( Date of Earliest Event Reported): December 30, 2011 Commission file number: 000-54167 Sanomedics International Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3320809 (State or oth |
|
| January 6, 2012 |
EXHIBIT 16.1 January 6, 2012 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Dear Sir or Madam: We have read the statements of Sanomedics International Holdings, Inc. (the “Company”) pertaining to our firm included under Item 4.01 of Form 8-K dated December 30, 2011 and agree with such statements as they pertain to our firm. We have no basis to agree or disagree with oth |
